AnalystsSteve Seedhouse
Steve Seedhouse's Stock Forecasts

Analyst Ranking
Top 20%
#1060 out of 5510 analysts
Average Return
+14.33%
Win Rate
69%22 out of 32
Risk vs Reward
Poor
Good

Steve Seedhouse's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abcellera Biologics IncABCL
+133.69%$4.66$10.89
2026-05-05 -
2026-09-11
Strong Buy
Apellis Pharmaceuticals IncAPLS
+125.77%$17.89$40.39
2026-03-18 -
2026-04-01
Strong Buy
Xencor IncXNCR
+107.04%$11.79$24.41
2025-10-06 -
2026-09-11
Strong Buy
Apellis Pharmaceuticals IncAPLS
+89.36%$21.33$40.39
2026-01-13 -
2026-04-01
Strong Buy
Apellis Pharmaceuticals IncAPLS
+78.78%$22.95$41.03
2025-08-01 -
2026-05-15
Strong Buy

Steve Seedhouse Analyst Color

Get additional color on Steve Seedhouse's coverage of popular stocks

Steve Seedhouse's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Belite Bio IncBLTE
3Strong Buy$270.00+55.36%Maintains
a month ago
Innoviva IncINVA
3Strong Buy$34.00+64.57%Maintains
a month ago
Inflarx NvIFRX
2Strong Buy$6.00+187.08%Maintains
a month ago
Eyepoint IncEYPT
2Strong Buy$55.00+1,200.24%Maintains
a month ago
Xencor IncXNCR
3Strong Buy$44.00+80.25%Maintains
a month ago
Abcellera Biologics IncABCL
2Strong Buy$12.00+10.19%Maintains
a month ago
Aligos Therapeutics IncALGS
1Strong Buy$20.00+283.14%Initiates Coverage On
4 months ago
Harrow IncHROW
3Strong Buy$88.00+155.22%Maintains
4 months ago
Viking Therapeutics IncVKTX
1Strong Buy$100.00+212.70%Maintains
4 months ago
Apellis Pharmaceuticals IncAPLS
4HoldN/AN/ADowngrades
5 months ago
Opus Genetics IncIRD
1Strong Buy$15.00+148.34%Initiates Coverage On
5 months ago
Surrozen IncSRZN
2Strong Buy$40.00+110.53%Reiterates
6 months ago
Korro Bio IncKRRO
3Strong Buy$22.00+59.30%Maintains
6 months ago
Wave Life Sciences IncWVE
2Strong Buy$41.00+793.25%Maintains
7 months ago
Camp4 Therapeutics CorpCAMP
1Strong Buy$7.00+64.71%Initiates Coverage On
a year ago
Tvardi Therapeutics IncTVRD
1Strong Buy$52.00N/AInitiates Coverage On
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.